Productivity-cost controversies in cost-effectiveness analysis: Review andresearch agenda

Citation
Ea. Rothermich et Ds. Pathak, Productivity-cost controversies in cost-effectiveness analysis: Review andresearch agenda, CLIN THER, 21(1), 1999, pp. 255-267
Citations number
61
Categorie Soggetti
Pharmacology
Journal title
CLINICAL THERAPEUTICS
ISSN journal
01492918 → ACNP
Volume
21
Issue
1
Year of publication
1999
Pages
255 - 267
Database
ISI
SICI code
0149-2918(199901)21:1<255:PCICAR>2.0.ZU;2-Z
Abstract
Productivity costs represent true costs to society and should not be ignore d in a cost-effectiveness analysis. However, there is dissension among heal th economists regarding measurement of productivity costs. Certain health e conomists argue for inclusion of productivity costs in the denominator of t he cost-effectiveness ratio, measured in quality-adjusted life-years. Other s argue that productivity costs should be included in the numerator of the cost-effectiveness ratio, measured in dollars using the friction-cost metho d or the human-capital method. This paper reviews the productivity-cost con troversies and offers suggestions for future research addressing the debate d issues.